Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Plasma glucagon and alanine responses to acute insulin deficiency in man.

Gerich JE, Tsalikian E, Lorenzi M, Karam JH, Bier DM.

J Clin Endocrinol Metab. 1975 Mar;40(3):526-9.

PMID:
1117061
3.

Prevention of human diabetic ketoacidosis by somatostatin. Evidence for an essential role of glucagon.

Gerich JE, Lorenzi M, Bier DM, Schneider V, Tsalikian E, Karam JH, Forsham PH.

N Engl J Med. 1975 May 8;292(19):985-9.

PMID:
804137
5.

Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.

Scheen A, Castillo M, Jandrain B, Krzentowski G, Henrivaux P, Luyckx AS, Lefèbvre PJ.

Diabetes Care. 1984 Jul-Aug;7(4):338-42.

PMID:
6381007
6.

Role of glucagon in human diabetic ketoacidosis: studies using somatostatin.

Gerich JE, Schneider VS, Lorenzi M, Tsalikian E, Karam JH, Bier DM, Forsham PH.

Clin Endocrinol (Oxf). 1976;5 Suppl:299S-305S.

PMID:
829924
7.

Is glucagon important in stable insulin-dependent diabetics?

Barnes AJ, Bloom A, Crowley MF, Tuttlebee JW, Bloom SR, Alberti KG, Smythe P, Turnell D.

Lancet. 1975 Oct 18;2(7938):734-7.

PMID:
52770
8.

[Role of insulin and counter-regulatory hormones in the metabolic changes caused by insulin deprivation in diabetic patients].

Castillo MJ, Scheen AJ, Gualda P, Lefebvre PJ.

Rev Esp Fisiol. 1989 Mar;45(1):53-9. Spanish.

PMID:
2664924
9.

Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

Diabetes Care. 1995 Nov;18(11):1452-9.

PMID:
8722069
10.

Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.

Tuttle KR, Marker JC, Dalsky GP, Schwartz NS, Shah SD, Clutter WE, Holloszy JO, Cryer PE.

Am J Physiol. 1988 Jun;254(6 Pt 1):E713-9.

PMID:
3287952
11.

The metabolic response to insulin deprivation in idiopathic brittle diabetes.

Husband DJ, Pernet A, Gill GV, Hanning I, Alberti KG.

Diabetes Res. 1986 May;3(4):193-8.

PMID:
3527516
12.

The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.

Yajnik CS, Shelgikar KM, Naik SS, Kanitkar SV, Orskov H, Alberti KG, Hockaday TD.

Diabetes Res Clin Pract. 1992 Feb;15(2):149-56.

PMID:
1563331
13.

Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.

Pontiroli AE, Perfetti MG, Andreotti AC, Fattor B, Monti LD, Pozza G.

Metabolism. 1993 Oct;42(10):1242-8.

PMID:
8105365
14.

Interactions of stress hormones on lipid and carbohydrate metabolism in man with partial insulin deficiency.

Pernet A, Johnston DG, Hammond V, Orskov H, Alberti KG.

Eur J Clin Invest. 1986 Aug;16(4):310-5.

PMID:
2875880
15.
16.

Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.

Paolisso G, Buonocore S, Gentile S, Sgambato S, Varricchio M, Scheen A, D'Onofrio F, Lefèbvre PJ.

Diabetologia. 1990 May;33(5):272-7.

PMID:
2198186
17.

Metabolic responses to intraduodenal glucose loading in insulin-infused diabetic dogs.

Stevenson RW, Orskov H, Parsons JA, Alberti KG.

Am J Physiol. 1983 Aug;245(2):E200-8.

PMID:
6349384
18.
19.

Alanine and terbutaline in treatment of hypoglycemia in IDDM.

Wiethop BV, Cryer PE.

Diabetes Care. 1993 Aug;16(8):1131-6.

PMID:
8375243
20.

Ketoacidosis in pancreatectomized man.

Barnes AJ, Bloom SR, Goerge K, Alberti GM, Smythe P, Alford FP, Chisholm DJ.

N Engl J Med. 1977 Jun 2;296(22):1250-3.

PMID:
404553

Supplemental Content

Support Center